Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural vs IV Dexmedetomidine for QL Block in Pediatric Pyeloplasty
NCT03885804Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Time to first analgesic requirement at 24 hours. Started Mar 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03885804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885804.